BioNexus raises an undisclosed amount seed

◆ Announced

7 Aug 2026

◆ Company

◆ Source

◆ The Round

BioNexus raised an undisclosed amount in seed funding, announced on 7 August 2026, led by Bass Ventures, with participation from SMB Investment Partners. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About BioNexus

AI-powered biotech R&D startup developing an AI scientist agent platform for drug discovery and biomedical research. BioNexus is based in South Korea and currently at seed stage, operating in Biotech, AI & ML.

◆ Investors

◆ Market context

This funding event is a citable node in Fusion42's market graph: it links BioNexus's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market